Protocols
1 protocol(s) meet the specified criteria
Drug: ASP8273
Protocol No.TitleStatus
8273-CL-0102An Open-label, Phase 1 Dose Escalation Study of Oral ASP8273 in Subjects with Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsOpen